Apricus Wealth, LLC Novartis Ag Transaction History

Apricus Wealth, LLC

$150 Million
Q3 2024

A detailed history of Apricus Wealth, LLC transactions in Novartis Ag stock. As of the latest transaction made, Apricus Wealth, LLC holds 21,213 shares of NVS stock, worth $2.19 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

21,213

Previous 29,916 29.09%

Holding current value

$2.19 Million

Previous $3.18 Million 23.4%

% of portfolio

1.63%

Previous 2.31%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$106.13 - $120.89 $923,649 - $1.05 Million	-8,703 Reduced 29.09%	21,213 $2.44 Million
Q2 2024 Jul 25, 2024	SELL	$92.57 - $107.37 $102,289 - $118,643	-1,105 Reduced 3.56%	29,916 $3.18 Million
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $22,007 - $25,056	231 Added 0.75%	31,021 $3 Million
Q4 2023 Jan 22, 2024	BUY	$92.27 - $101.54 $48,995 - $53,917	531 Added 1.75%	30,790 $3.11 Million
Q3 2023 Oct 24, 2023	BUY	$94.73 - $105.13 $72,278 - $80,214	763 Added 2.59%	30,259 $3.08 Million
Q2 2023 Jul 20, 2023	SELL	$92.52 - $104.91 $4,163 - $4,720	-45 Reduced 0.15%	29,496 $2.98 Million
Q1 2023 May 01, 2023	BUY	$80.03 - $92.81 $44,816 - $51,973	560 Added 1.93%	29,541 $2.72 Million
Q4 2022 Jan 31, 2023	BUY	$75.55 - $92.52 $109,547 - $134,154	1,450 Added 5.27%	28,981 $2.63 Million
Q3 2022 Oct 31, 2022	BUY	$74.61 - $87.26 $44,766 - $52,356	600 Added 2.23%	27,531 $2.09 Million
Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $142,520 - $165,937	1,770 Added 7.03%	26,931 $2.28 Million
Q1 2022 Apr 21, 2022	BUY	$80.11 - $90.62 $140,593 - $159,038	1,755 Added 7.5%	25,161 $2.3 Million
Q4 2021 Mar 09, 2022	BUY	$79.7 - $88.13 $1.87 Million - $2.06 Million	23,406 New	23,406 $2.05 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apricus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apricus Wealth, LLC with notifications on news.

Account

Apricus Wealth, LLC Novartis Ag Transaction History